Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 30, 2023
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PETStanley Fayn, A Paden King, Nicholas T Gutsche, et al.
Plos One|October 23, 2013
Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastomaJun S Wei, Peter Johansson, Li Chen, et al.
JAMA|November 20, 2008
Nosocomial transmission of human granulocytic anaplasmosis in ChinaLijuan Zhang, Yan Liu, Daxin Ni, et al.
Molecular Therapy. Oncology|October 29, 2025
GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenograftsReona Okada, Mia Fanuzzi, Constanza Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for RadiotheranosticsPhilip Homan, Joon-Yong Chung, Woonghee Lee, et al.
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Biorxiv : the Preprint Server for Biology|November 9, 2021
Camel nanobodies broadly neutralize SARS-CoV-2 variantsJessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Neoplasia (New York, N.Y.)|October 4, 2024
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferationYingwei Huang, Qiqi Wang, Weiwei Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variantsJessica Hong, Hyung Joon Kwon, Raul Cachau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PETStanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Pageof 21